From Ideas to Impact: Emerging Health Technologies in Action

1 – 2 Jun 2026 | Brussels, Belgium

Register
Register
Register

Nexuswelt Group - EU Funding and Innovation Agency

Company (SME)

nexuswelt.com/Munich, Germany

About

Nexuswelt is a European funding and innovation consultancy supporting organisations in building strong international partnerships and contributing to collaborative project development.

For Horizon Europe and other EU-funded activities, our main strengths include consortium building, partner search and positioning, proposal development, dissemination and communication, stakeholder engagement, exploitation support, and business- and market-oriented project framing. We help organisations identify suitable partners, strengthen collaboration structures, and position project ideas for credible impact and future uptake.

For this event, we are particularly interested in connecting with coordinators, industrial partners, research organisations, SMEs, and innovation actors active in clean industry, industrial decarbonisation, sustainability, advanced technologies, and competitive European value chains.

We are open to collaboration in both proposal preparation and project implementation, especially where strong communication, stakeholder outreach, project visibility, exploitation thinking, and strategic consortium support are needed.

Social media

Areas of Activity

IHI Topic 1: IHI European healthcare incubator networkHORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers (RIA)HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC) (IA)HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine (RIA)HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients (RIA)HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatmentHORIZON_MISS-2027-02-CANCER-03 Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypesHORIZON_MISS-2027-02-CANCER-04 Improving equitable health outcomes and added value for and with cancer patients through health-economics research, health systems research and outcomes research

Representatives

CEO

Nexuswelt Group - EU Funding and Innovation Agency